The U.S. federal court ruling that President Trump had overstepped his authority on imposing tariffs marked a clear setback ...

The U.S. federal court ruling that President Trump had overstepped his authority on imposing tariffs marked a clear setback ...

Quantum-enhanced drug discovery emerges as a leading investment trend within the pharmaceutical sector for 2025. Since the ...

Such deals allow Chinese firms to profit while minimising capital outlays, but also carry risks, law firm says.

The COVID-19 pandemic, climate change and wars have combined to hamper global governments' plans to reduce tobacco use, ...

Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announced that its shareholders approved all voting items at today’s Ordinary Annual General Meeting. A total of 9,135,061 ordinary shares ...

Dr. Raza Bokhari, Company's Former CEO, Paid $2.35 Million USD in Non-Dilutive Cash to Cover Legal and Other Costs Determined in the Arbitral Award Over the Past 4 Years ...

U.S. President Donald Trump heads to Pittsburgh, Pennsylvania on Friday to headline a rally to celebrate Nippon Steel's ...

As global shortages hit Ozempic and Wegovy, rivals like Eli Lilly gain ground, including in India’s growing market for ...

Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...

CPHI & PMEC China will be returning to the Shanghai New International Expo Center from June 24-26 amid a marked surge in international interest, with industry momentum rebounding following a string of ...

Onesource Specialty, a newly demerged pharma CDMO, is set to benefit from the $150 billion GLP-1 weight-loss drug boom with ...